Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9439628rdf:typepubmed:Citationlld:pubmed
pubmed-article:9439628lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9439628lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9439628lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9439628lifeskim:mentionsumls-concept:C0055673lld:lifeskim
pubmed-article:9439628lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:9439628lifeskim:mentionsumls-concept:C0007382lld:lifeskim
pubmed-article:9439628lifeskim:mentionsumls-concept:C0600115lld:lifeskim
pubmed-article:9439628lifeskim:mentionsumls-concept:C0450363lld:lifeskim
pubmed-article:9439628lifeskim:mentionsumls-concept:C0103306lld:lifeskim
pubmed-article:9439628pubmed:issue1lld:pubmed
pubmed-article:9439628pubmed:dateCreated1998-2-12lld:pubmed
pubmed-article:9439628pubmed:abstractTextAlthough angiotensin (ANG)-I is a substrate sensitive to chymase, the cleavage site differs among the chymase families. While human chymase (HC) hydrolyses the Phe8-His9 bond of ANG-I to ANG-II, rat chymase (RMCP-I) degrades the Tyr4-Ile5 bond of ANG-I to the inactive fragments. To clarify this different catalysis for ANG-I at the atomic level, three-dimensional structures of HC and RMCP-I were constructed by the molecular dynamic simulation. The energy-refined models clearly showed the significant difference in the electrostatic potential of the solvent surface. From the modeling study of their complex structures with ANG-I, the functional difference between both enzymes was clearly related with the electrostatic difference, especially at the C-terminal substrate-binding site.lld:pubmed
pubmed-article:9439628pubmed:languageenglld:pubmed
pubmed-article:9439628pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9439628pubmed:citationSubsetIMlld:pubmed
pubmed-article:9439628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9439628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9439628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9439628pubmed:statusMEDLINElld:pubmed
pubmed-article:9439628pubmed:monthJanlld:pubmed
pubmed-article:9439628pubmed:issn0006-291Xlld:pubmed
pubmed-article:9439628pubmed:authorpubmed-author:IshidaTTlld:pubmed
pubmed-article:9439628pubmed:authorpubmed-author:MiyazakiMMlld:pubmed
pubmed-article:9439628pubmed:authorpubmed-author:TakaiSSlld:pubmed
pubmed-article:9439628pubmed:authorpubmed-author:YamamotoDDlld:pubmed
pubmed-article:9439628pubmed:authorpubmed-author:OkunishiHHlld:pubmed
pubmed-article:9439628pubmed:authorpubmed-author:ShiotaNNlld:pubmed
pubmed-article:9439628pubmed:issnTypePrintlld:pubmed
pubmed-article:9439628pubmed:day6lld:pubmed
pubmed-article:9439628pubmed:volume242lld:pubmed
pubmed-article:9439628pubmed:ownerNLMlld:pubmed
pubmed-article:9439628pubmed:authorsCompleteYlld:pubmed
pubmed-article:9439628pubmed:pagination158-63lld:pubmed
pubmed-article:9439628pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:meshHeadingpubmed-meshheading:9439628-...lld:pubmed
pubmed-article:9439628pubmed:year1998lld:pubmed
pubmed-article:9439628pubmed:articleTitleThree-dimensional molecular modeling explains why catalytic function for angiotensin-I is different between human and rat chymases.lld:pubmed
pubmed-article:9439628pubmed:affiliationMedical Computation Center, Osaka Medical College, Japan.lld:pubmed
pubmed-article:9439628pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9439628pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9439628pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9439628lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9439628lld:pubmed